five

Table_1_Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease.DOCX

收藏
NIAID Data Ecosystem2026-03-13 收录
下载链接:
https://figshare.com/articles/dataset/Table_1_Interaction_Between_Treatment_and_Age_or_Sex_in_Non-ST-Segment_Elevation_Acute_Coronary_Disease_and_Three-Vessel_Disease_DOCX/19955975
下载链接
链接失效反馈
官方服务:
资源简介:
AimsTo explore the effects of age and sex on the outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients with the three-vessel disease (TVD). Methods and ResultsThe study is a subanalysis of data from a prospective cohort of 8,943 patients with angiographically confirmed TVD at Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China. The primary end point was major adverse cardiac and cerebrovascular events (MACCEs), a composite of all-cause death, myocardial infarction, and stroke. In total, 2,819 patients with NSTE-ACS who received CABG (43.6%) or PCI (56.4%) were included, among whom 32.7% were of 65–74 years, 7.2% were ≥75 years, and 22.6% were women. The median follow-up duration was 6.8 years. The superiority of CABG relative to PCI in terms of MACCE was decreased with age (adjusted hazard ratio [HR] [95% confidence interval (CI)]: <65 years: 0.662 [0.495–0.885], p = 0.005; 65–74 years: 0.700 [0.512–0.956], p = 0.025; ≥75 years: 0.884 [0.529–1.479], p = 0.640) and was only seen in men (adjusted HR [95% CI]: men: 0.668 [0.526–0.848], p = 0.001; women: 0.713 [0.505–1.006], p = 0.054). Significant treatment-by-sex and treatment-by-age interactions were observed in patients ≥ 75 years and women, respectively, (pinteraction with sex = 0.001; pinteraction with age = 0.002). ConclusionCoronary artery bypass grafting is favorable for most NSTE-ACS patients with TVD. The preponderance of CABG over PCI disappeared in patients ≥ 75 years and women. PCI is superior in women ≥ 75 years.
创建时间:
2022-06-02
二维码
社区交流群
二维码
科研交流群
商业服务